Method of utilizing neurotrophins to manipulate reproductive capacity
View Patent ↗Methods and kits are provided for manipulating and predicting the reproductive capacity of a female subject. The presence of endogenous neurotrophins and addition of exogenous neurotrophins, particularly BDNF, NT-4/5, and NGF, increase the reproductive capacity of a female patient by binding to receptors on the oocytes and stimulating maturation of the oocytes. Administration of antagonists act as a contraceptive because the antagonists prevent the neurotrophins from binding to oocyte receptors. Neurotrophins may also be used to stimulate the maturation of oocyte in vitro.
1. A method for testing viability of an oocyte from a woman, comprising:
extracting at least one oocyte;
administering brain derived neurotrophic factor, NT-4/5, or NGF to the oocyte under condition at which the brain derived neurotrophic factor, NT-4/5, or NGF binds to a brain derived neurotrophic factor, NT-4/5, or NGF receptors on the oocyte;
washing the oocyte to remove any excess, unbound brain derived neurotrophic factor, NT-4/5, or NGF;
administering monoclonal antibodies with a related specific binding affinity for brain derived neurotrophic factor, NT-4/5, or NGF under conditions at which the monoclonal antibodies bind to the bound brain derived neurotrophic factor, NT-4/5, or NGF on the oocyte;
washing the oocytes to remove any unbound monoclonal antibodies; and
measuring bound monoclonal antibodies,
wherein the presence of bound monoclonal antibodies indicative of brain derived neurotrophic factor, NT-4/5, or NGF bound to the oocyte is a positive prognosticator of oocyte viability and the absence of bound monoclonal antibody indicative of brain derived neurotrophic factor, NT-4/5, or NGF bound to the oocyte is a negative prognosticator of oocyte viability.
2. The method of claim 1 , wherein the antibodies are labeled.
3. The method of claim 2 , wherein the labeling material is fluorescent material or radioactive material.